|
Name |
Methyl dichloroasterrate
|
Molecular Formula | C18H16Cl2O8 | |
IUPAC Name* |
methyl 3,5-dichloro-2-hydroxy-6-(4-hydroxy-2-methoxy-6-methoxycarbonylphenoxy)-4-methylbenzoate
|
|
SMILES |
CC1=C(C(=C(C(=C1Cl)OC2=C(C=C(C=C2OC)O)C(=O)OC)C(=O)OC)O)Cl
|
|
InChI |
InChI=1S/C18H16Cl2O8/c1-7-12(19)14(22)11(18(24)27-4)16(13(7)20)28-15-9(17(23)26-3)5-8(21)6-10(15)25-2/h5-6,21-22H,1-4H3
|
|
InChIKey |
UWTOESDPWKUNBD-UHFFFAOYSA-N
|
|
Synonyms |
Methyl dichloroasterrate; methyl 3,5-dichloro-2-hydroxy-6-(4-hydroxy-2-methoxy-6-methoxycarbonylphenoxy)-4-methylbenzoate; 398118-62-2; metyl dichloroasterrate; Geodinhydrat-methylester; CHEMBL511994; Methyl 3,5-Dichloroasterric Acid; DTXSID601346316; ZINC14618675; AKOS030213163; 3,5-Dichloroasterric acid methyl ester; Methyl 2,4-dichloroasterrate, >=95% (LC/MS-UV); benzoic acid, 3,5-dichloro-2-hydroxy-6-[4-hydroxy-2-methoxy-6-(methoxycarbonyl)phenoxy]-4-methyl-, methyl ester; methyl 3,5-dichloro-2-hydroxy-6-[4-hydroxy-2-methoxy-6-(methoxycarbonyl)phenoxy]-4-methylbenzoate; NCGC00347615-02!methyl 3,5-dichloro-2-hydroxy-6-(4-hydroxy-2-methoxy-6-methoxycarbonylphenoxy)-4-methylbenzoate
|
|
CAS | 398118-62-2 | |
PubChem CID | 637419 | |
ChEMBL ID | CHEMBL511994 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 431.2 | ALogp: | 4.6 |
HBD: | 2 | HBA: | 8 |
Rotatable Bonds: | 7 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 112.0 | Aromatic Rings: | 2 |
Heavy Atoms: | 28 | QED Weighted: | 0.656 |
Caco-2 Permeability: | -4.858 | MDCK Permeability: | 0.00002090 |
Pgp-inhibitor: | 0.012 | Pgp-substrate: | 0 |
Human Intestinal Absorption (HIA): | 0.064 | 20% Bioavailability (F20%): | 0.003 |
30% Bioavailability (F30%): | 0.001 |
Blood-Brain-Barrier Penetration (BBB): | 0.009 | Plasma Protein Binding (PPB): | 100.26% |
Volume Distribution (VD): | 0.465 | Fu: | 3.09% |
CYP1A2-inhibitor: | 0.685 | CYP1A2-substrate: | 0.954 |
CYP2C19-inhibitor: | 0.908 | CYP2C19-substrate: | 0.27 |
CYP2C9-inhibitor: | 0.908 | CYP2C9-substrate: | 0.925 |
CYP2D6-inhibitor: | 0.237 | CYP2D6-substrate: | 0.385 |
CYP3A4-inhibitor: | 0.405 | CYP3A4-substrate: | 0.214 |
Clearance (CL): | 10.424 | Half-life (T1/2): | 0.569 |
hERG Blockers: | 0.006 | Human Hepatotoxicity (H-HT): | 0.151 |
Drug-inuced Liver Injury (DILI): | 0.612 | AMES Toxicity: | 0.018 |
Rat Oral Acute Toxicity: | 0.796 | Maximum Recommended Daily Dose: | 0.932 |
Skin Sensitization: | 0.495 | Carcinogencity: | 0.019 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.765 |
Respiratory Toxicity: | 0.378 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001395 | 0.651 | D06GCK | 0.300 | ||||
ENC001522 | 0.636 | D0WN0U | 0.294 | ||||
ENC006015 | 0.548 | D09DHY | 0.283 | ||||
ENC004226 | 0.538 | D09ELP | 0.270 | ||||
ENC001490 | 0.533 | D0C1SF | 0.264 | ||||
ENC002381 | 0.532 | D0Y7TS | 0.263 | ||||
ENC005937 | 0.532 | D02LZB | 0.263 | ||||
ENC002663 | 0.516 | D04OSE | 0.259 | ||||
ENC002526 | 0.515 | D0WY9N | 0.246 | ||||
ENC002468 | 0.484 | D0W7JZ | 0.241 |